Dentin sialophosphoprotein (DSPP) gene-silencing inhibits key tumorigenic activities in human oral cancer cell line, OSC2.
Abstract | BACKGROUND: METHODOLOGY/PRINCIPAL FINDINGS: Multiple regions of DSPP transcript were targeted for shRNA interference using hDSP- shRNA lentiviral particles designed to silence DSPP gene expression. Control shRNA plasmid encoding a scrambled sequence incapable of degrading any known cellular mRNA was used for negative control. Following puromycin selection of stable lines of DSSP-silenced OSC2 cells, phenotypic hallmarks of oral carcinogenesis were assayed by western blot and RT-PCR analyses, MTT (cell-viability), colony-formation, modified Boyden-Chamber (migration and invasion), and flow cytometry (cell-cycle and apoptosis) analyses. DSPP-silenced OSC2 cells showed altered cell morphology, reduced viability, decreased colony-formation ability, decreased migration and invasion, G0/G1 cell-cycle arrest, and increased tumor cell sensitivity to cisplatin-induced apoptosis. Furthermore, MMP-2, MMP-3, MMP-9, VEGF, Ki-67, p53, and EGFR were down-regulated. There was a direct correlation between the degree of DSPP-silencing and MMP suppression, as indicated by least squares regression: MMP-2 {(y = 0.850x, p<0.001) (y = 1.156x, p<0.001)}, MMP-3 {(y = 0.994x, p<0.001) (y = 1.324x, p = 0.004)}, and MMP-9 {(y = 1.248x, p = 0.005, y = 0.809, p = 0.013)}. CONCLUSIONS/SIGNIFICANCE: DSPP-silencing in OSC2 cell decreased salient hallmarks of oral tumorigenesis and provides the first functional evidence of a potential key role for DSPP in oral cancer biology. The down-regulation of MMP-2, MMP-3, MMP-9, p53 and VEGF in DSPP-silenced OSC2 cells provides a significant functional/molecular framework for deciphering the mechanisms of DSPP activities in oral cancer biology.
|
Authors | Rajeshree Joshi, Amany Tawfik, Nneka Edeh, Veronica McCloud, Stephen Looney, Jill Lewis, Stephen Hsu, Kalu U E Ogbureke |
Journal | PloS one
(PLoS One)
Vol. 5
Issue 11
Pg. e13974
(Nov 12 2010)
ISSN: 1932-6203 [Electronic] United States |
PMID | 21103065
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- Extracellular Matrix Proteins
- Phosphoproteins
- Sialoglycoproteins
- Tumor Suppressor Protein p53
- dentin sialophosphoprotein
- Matrix Metalloproteinase 3
- Matrix Metalloproteinase 2
- Matrix Metalloproteinase 9
- Cisplatin
|
Topics |
- Animals
- Antineoplastic Agents
(pharmacology)
- Apoptosis
(drug effects)
- Blotting, Western
- Cell Line
- Cell Line, Tumor
- Cell Movement
- Cisplatin
(pharmacology)
- Extracellular Matrix Proteins
(genetics, metabolism)
- Female
- Humans
- Keratinocytes
(cytology, metabolism)
- Matrix Metalloproteinase 2
(metabolism)
- Matrix Metalloproteinase 3
(metabolism)
- Matrix Metalloproteinase 9
(metabolism)
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Mouth Neoplasms
(genetics, pathology)
- Neoplasms, Experimental
(genetics, pathology)
- Phosphoproteins
(genetics, metabolism)
- RNA Interference
- Reverse Transcriptase Polymerase Chain Reaction
- Sialoglycoproteins
(genetics, metabolism)
- Transplantation, Heterologous
- Tumor Suppressor Protein p53
(metabolism)
- Up-Regulation
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|